IP update: vaccines, counterfeits, textbook piracy and tm translations

Here’s an update on what’s been happening in the world of IP lately:

Silfab acquires EnPV’s solar panel patent portfolio including the Self-Aligned Back Contact (SABC) technology and an associated trade mark. PV Tech, Solar Quarter, Technology News,

South Korean Supreme Court held that SK Bioscience’s export of its 13 valent pneumococcal vaccine does not infringe Pfizer’s Prevnar 13 patent. SK still can’t launch in South Korea itself until 2027 due to an earlier infringement judgment. ThePharmaLetter, Fiercepharma, KIPOST, FirstWordPharma

Temu joins the International Anti-Counterfeiting Coalition (IACC) to crack down on sale of counterfeit goods online. Retail Insider, RetailBoss, Technext,

US Federal Circuit clarifies trademark doctrine of foreign equivalents – “would a purchaser with ordinary sensibilities translate the word based on the context in which the mark is used?”: IPWatchDog; Intellectual Property & Technology, Justia, Bloomberg,

Google has copyright claims dismissed in textbook piracy case – but trademark case to continue based on ads: Plagiarism Today; Publishers Lunch; PYMNTS; TorrentFreak;

Moderna wins COVID vaccine patent case against Alnylam with a non infringement finding in US Court of Appeals for the Federal Circuit. A key issue was Alnylam’s definition (lexicography) in the patent specification: PatentlyO; Life Sciences Intellectual Property Review; Reuters; Bloomberg;

Discover more from Duncan Bucknell

Subscribe now to keep reading and get access to the full archive.

Continue reading